1. Home
  2. BCYC vs IPI Comparison

BCYC vs IPI Comparison

Compare BCYC & IPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCYC
  • IPI
  • Stock Information
  • Founded
  • BCYC 2009
  • IPI 2000
  • Country
  • BCYC United Kingdom
  • IPI United States
  • Employees
  • BCYC N/A
  • IPI N/A
  • Industry
  • BCYC Biotechnology: Pharmaceutical Preparations
  • IPI Mining & Quarrying of Nonmetallic Minerals (No Fuels)
  • Sector
  • BCYC Health Care
  • IPI Industrials
  • Exchange
  • BCYC Nasdaq
  • IPI Nasdaq
  • Market Cap
  • BCYC 565.5M
  • IPI 470.9M
  • IPO Year
  • BCYC 2019
  • IPI 2008
  • Fundamental
  • Price
  • BCYC $8.18
  • IPI $27.04
  • Analyst Decision
  • BCYC Buy
  • IPI Strong Sell
  • Analyst Count
  • BCYC 11
  • IPI 1
  • Target Price
  • BCYC $22.91
  • IPI $23.00
  • AVG Volume (30 Days)
  • BCYC 284.7K
  • IPI 184.3K
  • Earning Date
  • BCYC 10-31-2025
  • IPI 11-05-2025
  • Dividend Yield
  • BCYC N/A
  • IPI N/A
  • EPS Growth
  • BCYC N/A
  • IPI N/A
  • EPS
  • BCYC N/A
  • IPI N/A
  • Revenue
  • BCYC $19,281,000.00
  • IPI $225,166,000.00
  • Revenue This Year
  • BCYC N/A
  • IPI $10.01
  • Revenue Next Year
  • BCYC N/A
  • IPI N/A
  • P/E Ratio
  • BCYC N/A
  • IPI N/A
  • Revenue Growth
  • BCYC N/A
  • IPI 10.53
  • 52 Week Low
  • BCYC $6.10
  • IPI $20.86
  • 52 Week High
  • BCYC $25.39
  • IPI $39.01
  • Technical
  • Relative Strength Index (RSI)
  • BCYC 53.38
  • IPI 39.94
  • Support Level
  • BCYC $7.65
  • IPI $27.06
  • Resistance Level
  • BCYC $8.42
  • IPI $28.67
  • Average True Range (ATR)
  • BCYC 0.49
  • IPI 1.09
  • MACD
  • BCYC -0.05
  • IPI -0.05
  • Stochastic Oscillator
  • BCYC 40.38
  • IPI 43.06

About BCYC Bicycle Therapeutics plc

Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United States.

About IPI Intrepid Potash Inc

Intrepid Potash Inc produces and sells potash and potash byproducts in three main product segments: Potash, Trio, and Oilfield Solutions. The Potash segment produces and sells potash to the agricultural industry as a fertilizer input, the industrial market as a component of oil and gas drilling fluid, and the animal feed market as a nutrient supplement. The Trio segment produces and sells specialty fertilizer that consists of potassium, sulfate, and magnesium and is mined from langbeinite ore. The oilfield solutions segment offers water, high-speed potassium chloride mixing services, saltwater disposal services, and trucking services. The vast majority of revenue is generated in the United States, which is also the location of the firm's production facilities.

Share on Social Networks: